Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

Clinical trial NCT06063330 · COMPLETED

Trial details

NCT number: NCT06063330
Sponsor: Red Queen Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 Infectious Disease Symptomatic COVID-19 Infection Laboratory-Confirmed SARS CoV 2 Infection

Start date: 2023-09-27
Primary completion: 2024-01-03
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.